tirzepatide costa rica SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of *TIRZEPATIDA* -Es un medicamento inyectable

Gray market sources are unregulated

922, 968, 982 Coppelli, A

If your GERD symptoms are severe, frequent, or do not improve with simple measures, you should consult a healthcare provider

Activates both GLP-1 and GIP receptors, offering broader metabolic effects and potentially better appetite control

However, the lack of significant statistical interaction between subgroups (P = 0.127) suggests that addition of the AMPLITUDE-O trial has not changed the previous scenario [5], stressing that the net separation on MACE effect between patients with or without established CV disease may be more nuanced than suggested by previous meta-analyses [3]

Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N, et al